Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PolyPid Ltd. - Ordinary Shares (NQ:PYPD)

3.800 +0.010 (+0.26%)
Streaming Delayed Price Updated: 3:59 PM EST, Nov 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 81,310
Open 3.790
Bid (Size) 3.500 (200)
Ask (Size) 4.000 (100)
Prev. Close 3.790
Today's Range 3.750 - 3.880
52wk Range 2.300 - 3.930
Shares Outstanding 18,756,570
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
An Overlooked Crisis in Hospitals Could Be Pharma’s Next Great Opportunity
Via AB Newswire
These stocks are moving in today's pre-market session
Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill

Performance

YTD
+24.6%
+24.6%
1 Month
+14.1%
+14.1%
3 Month
+18.4%
+18.4%
6 Month
+39.7%
+39.7%
1 Year
+11.1%
+11.1%

More News

Read More
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Cisco To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
A Look Ahead: PolyPid's Earnings Forecast
Via Benzinga
Earnings Scheduled For February 12, 2025
Via Benzinga
Earnings Scheduled For November 13, 2024
Via Benzinga
PolyPid's Earnings: A Preview
Via Benzinga
POLYPID LTD (NASDAQ:PYPD) Reports Q2 2025 Results with Mixed Market Reaction Despite Positive Phase 3 D-PLEX₁₀₀ Data
Via Chartmill
PolyPid’s Game-Changing 60-Day GLP-1 Platform Could Disrupt $100B Weight Loss Market
Via AB Newswire
With Fresh Funding and Strong Phase 3 Data, PolyPid Advances Towards FDA Approval
Via News Direct
These stocks have an unusual volume in today's session
Via Chartmill
Nano-Cap PolyPid's Lead Drug Candidate Cuts Surgical Infection Risk by 38% In Phase 3 Trial
Via Benzinga
PYPD Stock Earnings: PolyPid Beats EPS for Q2 2024
Via InvestorPlace
PYPD Stock Earnings: PolyPid Beats EPS for Q1 2024
Via InvestorPlace
Earnings Scheduled For August 13, 2025
Via Benzinga
Earnings Scheduled For February 14, 2024
Via Benzinga
Why Circle Internet Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
This Excelerate Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Via Benzinga
Q1 Virtual Investor Summit: On-Demand Presentations Now Live
Via ACCESS Newswire
Earnings Scheduled For May 14, 2025
Via Benzinga
PolyPid Ltd. to Present at the Q1 Investor Summit Virtual Conference on March 11th, 2025
Via ACCESS Newswire
Kemper To Rally More Than 25%? Here Are 4 Top Analyst Forecasts For Thursday
Via Benzinga
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga

Frequently Asked Questions

Is PolyPid Ltd. - Ordinary Shares publicly traded?
Yes, PolyPid Ltd. - Ordinary Shares is publicly traded.
What exchange does PolyPid Ltd. - Ordinary Shares trade on?
PolyPid Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for PolyPid Ltd. - Ordinary Shares?
The ticker symbol for PolyPid Ltd. - Ordinary Shares is PYPD on the Nasdaq Stock Market
What is the current price of PolyPid Ltd. - Ordinary Shares?
The current price of PolyPid Ltd. - Ordinary Shares is 3.800
When was PolyPid Ltd. - Ordinary Shares last traded?
The last trade of PolyPid Ltd. - Ordinary Shares was at 11/06/25 03:59 PM ET
What is the market capitalization of PolyPid Ltd. - Ordinary Shares?
The market capitalization of PolyPid Ltd. - Ordinary Shares is 71.27M
How many shares of PolyPid Ltd. - Ordinary Shares are outstanding?
PolyPid Ltd. - Ordinary Shares has 71M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.